Abstract:BackgroundLarge-scale genetic screening using CRISPR-Cas9 technology has emerged as a powerful approach to uncover and validate gene functions. The ability to control the timing of genetic perturbation during CRISPR screens will facilitate precise dissection of dynamic and complex biological processes. Here, we report the optimization of a drug-inducible CRISPR-Cas9 system that allows high-throughput gene interrogation with a temporal control.ResultsWe designed multiple drug-inducible sgRNA expression vectors and measured their activities using an EGFP gene disruption assay in 11 human and mouse cell lines. The optimal design allows for a tight and inducible control of gene knockout in vitro, and in vivo during a seven-week-long experiment following hematopoietic reconstitution in mice. We next performed parallel genome-wide loss-of-function screens using the inducible and constitutive CRISPR-Cas9 systems. In proliferation-based dropout screens, these two approaches have similar performance in discriminating essential and nonessential genes. In a more challenging phenotypic assay that requires cytokine stimulation and cell staining, we observed similar sensitivity of the constitutive and drug-induced screening approaches in detecting known hits. Importantly, we demonstrate minimal leakiness of our inducible CRISPR screening platforms in the absence of chemical inducers in large-scale settings.ConclusionsIn this study, we have developed a drug-inducible CRISPR-Cas9 system that shows high cleavage efficiency upon induction but low background activity. Using this system, we have achieved inducible gene disruption in a wide range of cell types both in vitro and in vivo. For the first time, we present a systematic side-by-side comparison of constitutive and drug-inducible CRISPR-Cas9 platforms in large-scale functional screens. We demonstrate the tightness and efficiency of our drug-inducible CRISPR-Cas9 system in genome-wide pooled screening. Our design increases the versatility of CRISPR-based genetic screening and represents a significant upgrade on existing functional genomics toolbox.

High-content imaging-based pooled CRISPR screens in mammalian cells

High-content CRISPR screening

Expanding The Crispr Imaging Toolset With Staphylococcus Aureus Cas9 For Simultaneous Imaging Of Multiple Genomic Loci

Pooled Genome-Scale CRISPR Screens in Single Cells

CRISPRmap: Sequencing-free optical pooled screens mapping multi-omic phenotypes in cells and tissue

Multimodal optical pooled screening with CRISPRmap

Scalable single-cell pooled CRISPR screens with conventional knockout vector libraries

Protocol: Genome-scale CRISPR-Cas9 Knockout and Transcriptional Activation Screening

High-Throughput Screens in Mammalian Cells Using the Crispr-Cas9 System

Development of drug-inducible CRISPR-Cas9 systems for large-scale functional screening

Genetic and Pharmacological Interrogation of Cancer Vulnerability Using a Multiplexed Cell Line Screening Platform

Mapping multimodal phenotypes to perturbations in cells and tissue with CRISPRmap

Massively Parallel CRISPR‐Based Genetic Perturbation Screening at Single‐Cell Resolution

Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library

Rapid generation of homozygous fluorescent knock-in human cells using CRISPR–Cas9 genome editing and validation by automated imaging and digital PCR screening

High-Throughput Imaging of CRISPR- and Recombinant Adeno-Associated Virus-Induced DNA Damage Response in Human Hematopoietic Stem and Progenitor Cells

MIC-Drop: A platform for large-scale in vivo CRISPR screens

Efficient CRISPR/Cas9-mediated gene editing in mammalian cells by the novel selectable traffic light reporters

High-resolution characterization of gene function using single-cell CRISPR tiling screen

High-content CRISPR screening in tumor immunology

Imaging-based pooled CRISPR screening reveals regulators of lncRNA localization